Vilja Pietiäinen is a senior scientist at the Institute for Molecular Medicine Finland (FIMM) and a team leader of personalized urological tumor project (DEDUCER) and ERA PerMed -funded project on clinical implementation of multidimensional phenotypical drug sensitivities in paediatric precision oncology (COMPASS). Her research focuses on the systems medicine and precision therapeutics in cancer. She has M.Sc. in biochemistry and Ph.D. in virology/cell biology in 2005 (University of Edinburgh, U.K.; University of Helsinki-UH, Finland), and is an adjunct professor in cell and molecular biology. Currently, she is particularly dedicated to develop high-content phenotypic image-based characterization and ex vivo drug testing of patient-derived cancer cell models.